In earlier studies which showed that oestrogen activates the synthesis of RNA, DNA and protein in the blastocyst and uterus during delayed implantation, it was postulated that activation of the delayed blastocyst might be due to the direct action of oestrogen (Mohla, 1968;Prasad, Dass & Mohla, 1968;Dass, Mohla & Prasad, 1969).One of the earliest effects of oestrogen on the rat uterus is the release of adenosine 3\m='\5\m='\-monophosphate(cyclic ApMP), the levels of which are enhanced within 15 sec after the intravenous administration of oestrogen (Szego & Davis, 1967). Griffin & Szego (1968) showed that cyclic ApMP, like oestrogen, enhanced within 5 min the incorporation of labelled amino acids into the protein of uterine segments of untreated ovariectomized rats. They postulated that the cyclic ApMP released as a result of oestrogen treatment also participates in the early effects of oestrogen on the uterus. A further effect, noted within 5 min of treatment with oestrogen, is an increase in the incorporation of [3H]uridine into RNA in the blastocyst and uterus (Mohla & Prasad, 1970). It was, therefore, of interest to study the effect of cyclic ApMP on the incorpora¬ tion of [3H]uridine into RNA in the blastocyst and uterus of the rat during delayed implantation.Colony-bred, adult, virgin, female, albino rats of the Holtzman strain (240 to 280 g) were maintained in light-controlled (14 hr light/10 hr dark), airconditioned rooms (25 ± 1°C ) and fed a standard diet. Delayed implantation was induced by the method of Cochrane & Meyer (1957), i.e. mated females were bilaterally ovariectomized on Day 3 of pregnancy (the first day of finding spermatozoa in the vagina was designated Day 1 of pregnancy) and were given 4 mg/day of progesterone in olive oil till the termination of the experi¬ ment. Precursors were instilled into the uterine lumen according to methods described in our earlier studies (Prasad et al., 1968;Dass et al., 1969). The following experiments were performed on Day 9 of delayed implantation. N6-2-0 dibutyryl adenosine 3'5' monophosphate (cyclic ApMP, Cal. Biochem., Lot No. 920036) was dissolved in sterile physiological saline (pH 7-40). The experimental group (eight rats) received an intraluminal injection of 0-05 ml saline (pH 7-40) containing 1-25 mM cyclic ApMP and 1 /tc of [3H]uridine (Sp.Act. 6-0 Ci/mM; Schwartz Bioresearch)/uterine horn. The control animals (ten rats) received an intraluminal injection of 1 µ of [3H]uridine in 0-05 ml 327